Analysts Staying On The Sidelines On Cree Until Sales Return To 20% Growth
October 19, 2016 at 15:53 PM EDT
UBS said in a research note that it's keeping a Sell rating on the shares of Cree, Inc. (NASDAQ: CREE) until total sales growth returns ...